Bruno Märkl
Has participated in:
-
Phase I dose escalation study with the Lewis Y carbohydrate specific humanized antibody IGN311
-
Expression of abelson interactor 1 (Abi1) correlates with inflammation, KRAS mutation and adenomatous change during colonic carcinogenesis
-
Number of pathologists in Germany: comparison with European countries, USA, and Canada
-
Number of pathologists in Germany: comparison with European countries, USA, and Canada